Daniel J. Brennan - 15 Feb 2023 Form 4 Insider Report for BOSTON SCIENTIFIC CORP (BSX)

Role: EVP and CFO
Signature: /s/ Susan Thompson, Attorney-in-Fact
Issuer symbol: BSX
Transactions as of: 15 Feb 2023
Transactions value $: -$358,617
Form type: 4
Filing time: 16 Feb 2023, 18:15:47 UTC
Previous filing: 15 Feb 2023
Next filing: 21 Feb 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	BSX	Common Stock	Options Exercise	$56K	+7.57K	+2.77%	$7.39^*	281K	15 Feb 2023	Direct	F1
transaction	BSX	Common Stock	Options Exercise	$0	+4.15K	+1.48%	$0.00	285K	15 Feb 2023	Direct	F2
transaction	BSX	Common Stock	Tax liability	-$57.6K	-1.22K	-0.43%	$47.29	284K	15 Feb 2023	Direct
transaction	BSX	Common Stock	Sale	-$357K	-7.57K	-2.67%	$47.14	276K	15 Feb 2023	Direct	F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	BSX	Deferred Stock Units	Options Exercise	$0	-4.15K	-100%	$0.00^*	0	15 Feb 2023	Common Stock	4.15K		Direct	F2, F4
transaction	BSX	Stock Option (Right to Buy)	Options Exercise	$0	-7.57K	-100%	$0.00^*	0	15 Feb 2023	Common Stock	7.57K	$7.39	Direct	F1, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	The transactions reported in this Form 4 were effected pursuant to a pre-established Rule 10b5-1 trading plan.
F2	Each deferred stock unit represents the Company's commitment to issue one share of Boston Scientific common stock.
F3	Represents the weighted average sale price. These shares were sold in multiple transactions at prices ranging from $46.993 to $47.26, inclusive. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
F4	Shares of common stock will be issued to the reporting person in five equal annual installments beginning on February 15, 2019, the first anniversary of the date of grant.
F5	Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal installments beginning on February 28, 2014, the first anniversary of the date of grant.